Novartis AG Research and Development Expense
Novartis AG (NVSEF) reported Research and Development Expense of $11.20 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2026-02-04
- Novartis AG research and development expense for the quarter ending 2025-06-30 was $2.73B, a 15.21% increase year-over-year.
- Novartis AG research and development expense for the quarter ending 2024-06-30 was $2.37B, a 2.73% increase year-over-year.
- Novartis AG research and development expense for the quarter ending 2023-06-30 was $2.30B, a 7.77% decline year-over-year.
- Novartis AG research and development expense for the quarter ending 2022-06-30 was $2.50B, a 4.08% increase year-over-year.
| Period end | Research And Development Expense 3 month | Research And Development Expense 3 month as first filed | Research And Development Expense 6 month | Research And Development Expense 6 month as first filed | Research And Development Expense 12 month | Research And Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $11.20B 20-F · filed 2026-02-04 | |||||
| 2025-06-30 | $2.73B 6-K · filed 2025-07-17 | $5.09B 6-K · filed 2025-07-17 | ||||
| 2024-12-31 | $10.02B 20-F · filed 2026-02-04 | |||||
| 2024-06-30 | $2.37B 6-K · filed 2025-07-17 | $4.79B 6-K · filed 2025-07-17 | ||||
| 2023-12-31 | $11.37B 20-F · filed 2026-02-04 | |||||
| 2023-06-30 | $2.30B 6-K · filed 2024-07-18 | $2.53B 6-K · filed 2023-07-18 | $4.88B 6-K · filed 2024-07-18 | $5.32B 6-K · filed 2023-07-18 | ||
| 2022-12-31 | $9.17B 20-F · filed 2025-01-31 | $10.00B 20-F · filed 2023-02-01 | ||||
| 2022-06-30 | $2.50B 6-K · filed 2023-07-18 | $4.82B 6-K · filed 2023-07-18 | ||||
| 2021-12-31 | $8.64B 20-F · filed 2024-01-31 | $9.54B 20-F · filed 2022-02-02 | ||||
| 2021-06-30 | $2.40B 6-K · filed 2022-07-19 | $4.75B 6-K · filed 2022-07-19 | ||||
| 2020-12-31 | $8.98B 20-F/A · filed 2023-05-15 | |||||
| 2020-06-30 | $2.44B 6-K · filed 2021-07-21 | $4.50B 6-K · filed 2021-07-21 | ||||
| 2019-12-31 | $9.40B 20-F · filed 2022-02-02 | |||||
| 2019-06-30 | $2.05B 6-K · filed 2020-07-21 | $4.35B 6-K · filed 2020-07-21 | ||||
| 2018-12-31 | $8.49B 20-F · filed 2021-01-26 | $9.07B 20-F · filed 2019-01-30 | ||||
| 2018-06-30 | $2.13B 6-K · filed 2019-07-18 | $2.28B 6-K · filed 2018-07-18 | $4.11B 6-K · filed 2019-07-18 | $4.40B 6-K · filed 2018-07-18 | ||
| 2017-12-31 | $8.39B 20-F · filed 2020-01-29 | $8.97B 6-K · filed 2018-01-24 | ||||
| 2017-06-30 | $2.06B 6-K · filed 2018-07-18 | $4.23B 6-K · filed 2018-07-18 | ||||
| 2016-12-31 | $9.04B 20-F · filed 2019-01-30 | |||||
| 2015-12-31 | $8.94B 6-K · filed 2018-01-24 |